02.12.2024 - By We Are For Good
Meet Alice. For her, finding life-saving cancer treatments is personal, not just professional. With a career in biotech that's witnessed industry milestones, she now leads BrightEdge at the American Cancer Society. BrightEdge is a venture capital fund directing philanthropic donations to startups pioneering cancer-fighting solutions. Established in 2019, it's already invested $28.9 million in 18 companies, with the potential to benefit 1.5 million patients and families. Don't miss this inspiring discussion on driving impact and innovation in the fight against cancer.